Dexcom Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, said this week it is building a 180,000-square-foot manufacturing facility near Mesa for its growing business.
The state-of-the-art facility, projected to create more than 500 jobs over the next several years, is expected to begin manufacturing operations next year.
"We are thrilled to locate our new state of the art manufacturing facility in the Greater Phoenix Area where the health care industry is seeing accelerated growth," Dexcom President and CEO Kevin Sayer said. "We chose Mesa due to the available, talented workforce, in addition to the proximity to our headquarters in San Diego and our key suppliers. Given our company's growth, and the growing demand for CGM technology, we felt that a significant expansion of our manufacturing capability in this location was a good strategic fit."
Advances in technology have helped those with diabetes monitor their glucose levels. CGM is considered the most significant breakthrough in diabetes management in the past 40 years. With the recent introduction of the Dexcom G5 Mobile CGM System, people with diabetes can view glucose information on their iOS-enabled devices for real-time diabetes management. CGM also provides the direction and rate of glucose change with the push of a button and alerts users when glucose is too low or too high.
6340 Sequence Dr
San Diego, CA - 92121